Odisha Channel Bureau
Bhubaneswar: Bharat Biotech Int Ltd (BBIL) will set up a ‘state of the art’ advance vaccine manufacturing unit at Andharua in Bhubaneswar.
The BBIL unit at Andharua would produce 10 types of vaccines including malaria and COVID-19 vaccine, according to officials.
The land required for the facility has been made available by the Odisha government for ground breaking works.
State Chief Secretary Asit Tripathy has asked BBIL to set up a ‘state of the art’ biotech incubation center, common facilities and IT corridor.
“The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies, Pandemic Influenza, and drug-resistant Staphylococcus aureus,” according to Chairman and Managing Director Krishna Ella.
Presenting BBIL’s preparedness in the meeting on Friday, Dr. Ella said that the best of technology will be put in the Odisha unit.
The total investment in the project would be around Rs. 300 crore.
BBIL is a multi-dimensional biotechnology organisation specialising in manufacture of vaccines and bio-therapeutics.
The Chief Secretary has assured that BBIL would be provided all support for future expansion of the unit at Andharua.
Tripathy also directed the concerned authorities to start the ground level construction work within a fortnight and commence production within the scheduled time.
